A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial-Reference-Cited by-同舟云学术

A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial

Author:

Achebe Maureen M.¹,Glaspy John²,Kalra Philip A.³,Auerbach Michael⁴^ORCID,Thomsen Lars L.⁵,Bhandari Sunil⁶^ORCID

Affiliation:

1. Divison of Hematology, Brigham and Women's Hospital Dana Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA

2. Department of Medicine, Division of Hematology Oncology UCLA School of Medicine Los Angeles California USA

3. Department of Renal Medicine Salford Royal NHS Foundation Trust Salford UK

4. Department of Medicine Georgetown University School of Medicine Washington District of Columbia USA

5. Department of Clinical and Non‐Clinical Research Pharmacosmos A/S Holbaek Denmark

6. Department of Renal Medicine Hull University Teaching Hospitals NHS Trust Kingston upon Hull UK

Publisher

Wiley

Subject

Hematology

Link

Reference6 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron Deficiency in Pregnancy: A Health Inequity;The American Journal of Clinical Nutrition;2023-06